AMENDMENT TO LETTER AGREEMENTLetter Agreement • March 9th, 2017 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 9th, 2017 Company Industry JurisdictionThis Amendment to Letter Agreement (the “Amendment”) is entered into by Mirati Therapeutics, Inc., a Delaware corporation (the “Company”), and Christopher LeMasters (“Employee”) and shall be effective as of December 19, 2016.
AMENDMENT TO LETTER AGREEMENTLetter Agreement • March 9th, 2017 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 9th, 2017 Company Industry JurisdictionThis Amendment to Letter Agreement (the “Amendment”) is entered into by Mirati Therapeutics, Inc., a Delaware corporation (the “Company”), and Jamie A. Donadio (“Employee”) and shall be effective as of December 19, 2016.
AMENDMENT TO LETTER AGREEMENTLetter Agreement • March 9th, 2017 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 9th, 2017 Company Industry JurisdictionThis Amendment to Letter Agreement (the “Amendment”) is entered into by Mirati Therapeutics, Inc., a Delaware corporation (the “Company”), and Isan Chen, M.D. (“Employee”) and shall be effective as of December 19, 2016.
AMENDMENT TO LETTER AGREEMENTLetter Agreement • March 9th, 2017 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 9th, 2017 Company Industry JurisdictionThis Amendment to Letter Agreement (the “Amendment”) is entered into by Mirati Therapeutics, Inc., a Delaware corporation (the “Company”), and James Christensen, Ph.D. (“Employee”) and shall be effective as of December 19, 2016.